It’s brilliant that @ValnevaSE is starting the large-scale manufacture of its potential vaccine, creating 100 high-skilled jobs at their Livingston facility.

We’ve secured 60m doses due to be delivered by the end of the year if it is approved for use.

https://t.co/4pDUbczlVl